Concepedia

Mark F. McLaughlin

MF

Statistics

Publications

9

Citations

377

H-Index

9

Active since

1964

Affiliations

The University of Texas Southwestern Medical Center(Current)

Oak Ridge National Laboratory

University of Missouri

University of Tennessee at Knoxville

Mark F. McLaughlin is an author at The University of Texas Southwestern Medical Center specializing in medicine, radiation therapy, and oncology.

ORCID

Publications per year

1964–2023

9

Publications

9

Gold Coated Lanthanide Phosphate Nanoparticles for Targeted Alpha Generator Radiotherapy

Mark F. McLaughlin, Jonathan Woodward, R. A. Boll et al. · PLoS ONE · 2013 · 121 citations · Full text

, , +17

Phase 2 Trial of Stereotactic Ablative Radiotherapy for Patients with Primary Renal Cancer

Raquibul Hannan, Mark F. McLaughlin, Laurentiu M. Pop et al. · European Urology · 2023 · 60 citations · Full text

, , +15

LnPO <sub>4</sub> Nanoparticles Doped with Ac-225 and Sequestered Daughters for Targeted Alpha Therapy

Mark F. McLaughlin, David J. Robertson, Paul H. Pevsner et al. · Cancer Biotherapy and Radiopharmaceuticals · 2013 · 47 citations

, , +17

Hydrogel Spacer Rectal Wall Infiltration Associated With Severe Rectal Injury and Related Complications After Dose Intensified Prostate Cancer Stereotactic Ablative Radiation Therapy

Mark F. McLaughlin, Michael R. Folkert, Robert Timmerman et al. · Advances in Radiation Oncology · 2021 · 37 citations · Full text

, , +17

Stereotactic ablative radiation therapy for renal cell carcinoma with inferior vena cava tumor thrombus

Yuval Freifeld, Iván Pedrosa, Mark F. McLaughlin et al. · Urologic Oncology Seminars and Original Investigations · 2022 · 35 citations · Full text

, , +16

1–5 of 9